CCO Infectious Disease Podcast
By Clinical Care Options
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Clinical Care Options
Category: Courses
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 7
Reviews: 0
Episodes: 380
Description
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
| Episode | Date |
|---|---|
|
Integrating New Data From CROI 2024: Pharmacist Perspectives
|
Apr 29, 2024 |
|
How Primary Care Providers Can Expand Their Role in HBV Management
|
Apr 26, 2024 |
|
Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma
|
Apr 11, 2024 |
|
Linkage to Care After HBV Diagnosis: Sharing Session 3
|
Apr 10, 2024 |
|
Key HIV Studies From CROI 2024 Influencing Clinical Practice
|
Mar 29, 2024 |
|
How to Implement Earlier Hepatitis B Treatment
|
Mar 26, 2024 |
|
Empowering Patients With Education on HBV: Sharing Session 2
|
Mar 11, 2024 |
|
Switching HIV ART in Older People With Weight Gain and Cardiovascular Comorbidities
|
Mar 08, 2024 |
|
Optimizing ART in Priority Populations: Initiating ART in Transgender Women
|
Mar 04, 2024 |
|
COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug‒Drug Interactions
|
Feb 27, 2024 |
|
New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023
|
Feb 05, 2024 |
|
Reconsidering Your Approach: Strategies to Support PrEP Persistence and Reengagement
|
Jan 31, 2024 |
|
My Journey With HBV and HDV: Sharing Session 1
|
Jan 24, 2024 |
|
Why I Started and Why I Stayed on HIV PrEP
|
Jan 12, 2024 |
|
Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement
|
Jan 10, 2024 |
|
RSV Vaccines in Adults: A Risk-Based Approach
|
Dec 27, 2023 |
|
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening
|
Dec 22, 2023 |
|
Q&A on HIV PrEP: Episode 7 for Advanced Practice Providers
|
Dec 21, 2023 |
|
Mental Health Challenges: Dialogues on Optimizing Engagement in HIV Care
|
Dec 20, 2023 |
|
Starting ART: Dialogues on Optimizing Engagement in HIV Care
|
Dec 18, 2023 |
|
Engagement in Care: Dialogues on Optimizing Engagement in HIV Care
|
Dec 18, 2023 |
|
Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement
|
Dec 15, 2023 |
|
Selected FXR Agonist PBC Studies: Conference Coverage of AASLD
|
Dec 13, 2023 |
|
PrEP Talks: Strategies for Advanced Practice Providers to Increase Uptake
|
Dec 12, 2023 |
|
Where We Want to Be: The Search for a Cure for HIV
|
Dec 11, 2023 |
|
CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia
|
Dec 07, 2023 |
|
PrEP Talks: Uptake in Young Adults and Adolescents
|
Dec 07, 2023 |
|
Investigational PPAR-delta Agonist for PBC Treatment and Race-Based Considerations for PBC Diagnosis: Conference Coverage of AASLD
|
Dec 07, 2023 |
|
Investigational Dual PPAR Agonist, FXR Agonist With Fibrate, and Hyperlipidemia in People With PBC: Conference Coverage of AASLD
|
Dec 06, 2023 |
|
Are We Making Our Patients Fight for PrEP?
|
Dec 04, 2023 |
|
Q&A on HIV PrEP: Episode 6 on Cisgender Women
|
Dec 04, 2023 |
|
The Rise of RSV: Updates on Seasonality
|
Nov 30, 2023 |
|
Ready, Set, Vaccinate! RSV Vaccination for Older Adults
|
Nov 30, 2023 |
|
A Difficult Differential: Clinical Presentation and Diagnosis of RSV in Adults
|
Nov 30, 2023 |
|
Q&A on HIV PrEP: Episode 4 on Adolescents and Young Adults Part 2
|
Nov 30, 2023 |
|
Podcast on On-Demand PrEP: Strategies to Support PrEP Persistence and Reengagement
|
Nov 30, 2023 |
|
Role of Quantitative HBsAg Testing in Clinical Practice for People With CHB
|
Nov 29, 2023 |
|
Which Patients With Hepatitis B Should We Be Treating?
|
Nov 29, 2023 |
|
A Hidden Annual Epidemic: The Burden of RSV in Adults
|
Nov 29, 2023 |
|
Podcast on Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement
|
Nov 28, 2023 |
|
Trailblazers: Pharmacist’s Role in Optimizing New RSV Vaccines for Older Adults
|
Nov 27, 2023 |
|
Light on the Horizon: Developments in RSV Vaccines
|
Nov 21, 2023 |
|
Surveying the Landscape: Annual Burden of RSV in Older Adults
|
Nov 21, 2023 |
|
Q&A on HIV PrEP: Episode 5 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men Part 2
|
Nov 21, 2023 |
|
NDM-Producing Enterobacterales: Applying Best Practices in Complex Clinical Scenarios
|
Nov 16, 2023 |
|
DTR-Pseudomonas aeruginosa: Applying Best Practices in Complex Clinical Scenarios
|
Nov 16, 2023 |
|
Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios
|
Nov 15, 2023 |
|
Where We’re Going: The Next Wave of Antiretroviral Innovations
|
Nov 15, 2023 |
|
PrEP Today: An HIV Prevention Revolution
|
Nov 13, 2023 |
|
Unlocking the Promise of PrEP and the Future of PrEP
|
Nov 13, 2023 |
|
Burden of Uncomplicated Urinary Tract Infections
|
Nov 13, 2023 |
|
Best Practices in Managing Uncomplicated UTIs in the Emergency Department
|
Nov 13, 2023 |
|
Updates in Antimicrobial Selection for uUTIs
|
Nov 13, 2023 |
|
Frequently Asked Questions About CMV Management
|
Nov 06, 2023 |
|
Modernizing CMV Preventive Approaches
|
Nov 06, 2023 |
|
Beyond CMV Prevention
|
Nov 06, 2023 |
|
COVID-19 Update: Independent Conference Coverage of IDWeek 2023
|
Nov 06, 2023 |
|
Where We Are: Innovations in HIV Care Delivery
|
Nov 01, 2023 |
|
Emerging Scientific Data and Unique Clinical Scenarios in People With NTM Lung Disease
|
Oct 31, 2023 |
|
Guidelines-Based Treatment for NTM Lung Disease: Application in Complex Patients
|
Oct 31, 2023 |
|
Diagnosis of NTM Lung Disease: Art and Science
|
Oct 31, 2023 |
|
Barriers to HIV PrEP in Cisgender Women
|
Oct 23, 2023 |
|
Q&A on HIV PrEP: Episode 3 on Adolescents and Young Adults
|
Oct 23, 2023 |
|
Patient Perspectives on Barriers and Facilitators of HIV Care
|
Oct 18, 2023 |
|
Podcast 2: Managing COVID-19 Risk in Individuals With Metabolic Syndrome and Obesity
|
Oct 06, 2023 |
|
Podcast 1: Managing COVID-19 Risk in Individuals With Metabolic Syndrome and Obesity
|
Oct 02, 2023 |
|
Q&A on HIV PrEP: Episode 2 on Cisgender Women
|
Sep 27, 2023 |
|
Barriers to HIV PrEP in Adolescents
|
Sep 21, 2023 |
|
Integrating New Data on HIV Adverse Events From IAS 2023: Pharmacist Perspectives
|
Sep 15, 2023 |
|
Effective Patient‒Provider Communication for PrEP Persistence
|
Sep 14, 2023 |
|
Health-Related Quality of Life in People Living With HIV
|
Sep 12, 2023 |
|
Answering the Questions on Which HIV PrEP for Which Patient: Jill Blumenthal and Kenric Ware
|
Sep 12, 2023 |
|
What Challenges and Opportunities Exist With Implementation of Available Long-Acting ART?
|
Sep 11, 2023 |
|
Q&A on HIV PrEP: Episode 1 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men
|
Sep 08, 2023 |
|
RSV Recommendations From ACIP: How to Apply Them in Your Older Adults
|
Sep 08, 2023 |
|
Challenging Scenarios: Managing Virologic Failure in a Heavily Treatment–Experienced Patient
|
Aug 22, 2023 |
|
PrEP Talks: Uptake in Cisgender Women
|
Aug 08, 2023 |
|
Long-Acting Lipoglycopeptides for Skin and Soft Tissue Infections : Implementation Into Practice
|
Aug 08, 2023 |
|
People of Childbearing Potential and Their Infants: Overcoming HBV Barriers
|
Aug 03, 2023 |
|
Managing ART Failure: Answering the Questions
|
Aug 03, 2023 |
|
Challenging Scenarios: Managing a First ART Failure
|
Jul 26, 2023 |
|
PrEP Talks: Uptake in Racial and Ethnic Minority Men Who Have Sex With Men and Transgender Individuals
|
Jul 19, 2023 |
|
PrEP Initiation: Answering the Questions
|
Jul 13, 2023 |
|
Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023
|
Jul 11, 2023 |
|
Treatment of Skin and Soft Tissue Infections
|
Jul 11, 2023 |
|
Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley
|
Jul 03, 2023 |
|
Q&A on Barriers to HIV PrEP: Pharmacist Perspectives
|
Jun 27, 2023 |
|
Older Adults: Overcoming HBV Barriers
|
Jun 23, 2023 |
|
Hepatitis Delta in Focus: Episode 4 of Answering the Questions on Screening, Diagnosis, and Treatment
|
Jun 22, 2023 |
|
Preparing for the Fall: New RSV Vaccine Approvals
|
Jun 19, 2023 |
|
Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment
|
Jun 19, 2023 |
|
Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST
|
Jun 09, 2023 |
|
The Burden of Skin and Soft Tissue Infections: Epidemiology, Clinical Presentation, and Diagnosis
|
Jun 08, 2023 |
|
Choosing Between Initial ART Options: Answering the Questions
|
Jun 06, 2023 |
|
Choosing ART for HIV With HBV and HCV Coinfections: Using HIV-ASSIST
|
May 30, 2023 |
|
Integrating New Data on LA ART From CROI 2023: Pharmacist Perspectives
|
May 22, 2023 |
|
Christine Katlama and Babafemi Taiwo: Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV
|
May 16, 2023 |
|
Preconception ART Selection: Using HIV-ASSIST
|
May 11, 2023 |
|
Long-Acting ART: Cabotegravir Plus Rilpivirine
|
May 10, 2023 |
|
COVID-19 Update: Independent Conference Coverage of ECCMID 2023
|
May 05, 2023 |
|
2023 Audio Recap: Principles of Outpatient COVID-19 Management
|
May 03, 2023 |
|
Complicated Clinical Infections: Clinical Impact of New Data From ECCMID 2023
|
May 03, 2023 |
|
2023 Audio Recap: Practical Case Studies in Outpatient COVID-19 Management
|
May 02, 2023 |
|
Q&A: HDV Management Episode 2
|
Apr 26, 2023 |
|
Overcoming HBV Barriers: Focus on Asian American People
|
Apr 25, 2023 |
|
African Immigrant People: Overcoming HBV Barriers
|
Apr 25, 2023 |
|
Individualizing HIV ART: Considerations for Weight Gain
|
Apr 24, 2023 |
|
Rapid ART Initiation: Answering the Questions
|
Apr 21, 2023 |
|
Individualizing HIV ART: Rapid Start
|
Apr 13, 2023 |
|
Perspectives From Asia on Advances in HIV Treatment and Prevention
|
Mar 27, 2023 |
|
RSV in Adults: How It Presents
|
Mar 22, 2023 |
|
RSV in Adults: A Hidden Epidemic
|
Mar 22, 2023 |
|
Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV: José R. Arribas and Melissa Badowski
|
Mar 21, 2023 |
|
Answering the Questions on HIV PrEP Persistence
|
Mar 16, 2023 |
|
Answering Questions on Which HIV PrEP for Which Patient: Carolyn Chu and Samantha Strong
|
Mar 15, 2023 |
|
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
|
Mar 08, 2023 |
|
Barriers to HIV PrEP: Addressing Intersectionality
|
Mar 06, 2023 |
|
Long-Acting ART: Lenacapavir
|
Mar 03, 2023 |
|
Long-Acting PrEP: Monitoring for New HIV Infection
|
Mar 03, 2023 |
|
How to Screen for Hepatitis Delta Virus
|
Feb 23, 2023 |
|
Ensuring Linkage to Care for Patients Diagnosed With Hepatitis Delta Virus
|
Feb 23, 2023 |
|
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
|
Feb 23, 2023 |
|
Canadian Perspectives on Advances in HIV Treatment and Prevention
|
Feb 17, 2023 |
|
Australian Perspectives on Advances in HIV
|
Feb 17, 2023 |
|
Perspectives From Latin America on Advances in HIV PrEP
|
Feb 17, 2023 |
|
European Perspectives on Advances in HIV Treatment
|
Feb 17, 2023 |
|
Diagnosis and Management of Patients With Long COVID
|
Jan 31, 2023 |
|
The Role of College Campuses in HIV PrEP Uptake
|
Jan 31, 2023 |
|
How Clinic Facilities Can Prepare for Long-Acting Injectable Antiretroviral Therapy
|
Jan 18, 2023 |
|
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
|
Jan 17, 2023 |
|
Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe
|
Jan 13, 2023 |
|
Administration of LA ART by Community Nurses in France
|
Jan 05, 2023 |
|
Optimizing PrEP Selection and Persistence for MSM
|
Jan 05, 2023 |
|
PrEP Considerations for Transgender and Nonbinary Individuals
|
Jan 05, 2023 |
|
What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?
|
Jan 04, 2023 |
|
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
|
Jan 04, 2023 |
|
Should We Be Concerned About Viral Rebound With Antiviral Agents?
|
Dec 30, 2022 |
|
ART Selection in Treatment-Naive PWH: Weight Gain Considerations
|
Dec 30, 2022 |
|
Selecting First-line ART in Treatment-Naive Persons With HIV
|
Dec 29, 2022 |
|
If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?
|
Dec 29, 2022 |
|
Promoting Meningococcal Vaccine Equity in Adolescent Patients
|
Dec 29, 2022 |
|
Will New COVID-19 Vaccines Affect Risk Stratification?
|
Dec 27, 2022 |
|
The Future of Long-Acting HIV Care: What’s Still Needed
|
Dec 22, 2022 |
|
Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs
|
Dec 20, 2022 |
|
Answering the Questions on Monkeypox in PWH
|
Dec 19, 2022 |
|
Answering the Questions on Considering an ART Switch During Pregnancy
|
Dec 19, 2022 |
|
Expanding Access to Long-Acting ART in Europe
|
Dec 19, 2022 |
|
Whom to Screen for Hepatitis Delta Virus
|
Dec 15, 2022 |
|
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
|
Dec 15, 2022 |
|
What Patients Want in HIV Treatment and Prevention: Africa
|
Dec 14, 2022 |
|
What Patients Want in HIV Treatment and Prevention: Malaysia
|
Dec 07, 2022 |
|
Addressing ART Safety and Tolerability in Transgender Individuals
|
Dec 07, 2022 |
|
Practice-Changing Viral Hepatitis Data From AASLD 2022
|
Dec 06, 2022 |
|
Newest Viral Hepatitis Data From AASLD 2022
|
Dec 06, 2022 |
|
FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICU
|
Dec 06, 2022 |
|
Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap
|
Dec 05, 2022 |
|
COVID-19 Antiviral Agents and COVID-19 Rebound
|
Nov 22, 2022 |
|
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
|
Nov 18, 2022 |
|
Creative Strategies for Meningococcal Vaccine Uptake
|
Nov 17, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: Solutions
|
Nov 15, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: Cisgender Women
|
Nov 15, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: Transgender Women
|
Nov 15, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: People Who Inject Drugs
|
Nov 15, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: PrEP Inequities by Race
|
Nov 14, 2022 |
|
Cutting-Edge Concepts in HIV Care: PrEP
|
Nov 14, 2022 |
|
Linkage to Care After HBV Diagnosis in Asian Communities in the US
|
Nov 14, 2022 |
|
Cutting-Edge Concepts in HIV Care: Long-Acting Therapies
|
Nov 14, 2022 |
|
Ending the HIV Epidemic: Persistence on ART
|
Nov 14, 2022 |
|
Treatment Barriers in Asian Communities in the US
|
Nov 14, 2022 |
|
HBV Treatment and Retention in Care Among African Communities in the US
|
Nov 14, 2022 |
|
HBV Screening and Diagnosis Among African Communities in the US
|
Nov 14, 2022 |
|
Barriers and Solutions to Expanding PrEP Uptake: Adolescents
|
Nov 07, 2022 |
|
If RSV Vaccines Are Approved for Older Adults, What’s Next?
|
Nov 02, 2022 |
|
What Patients Want in HIV Treatment and Prevention: United Kingdom
|
Nov 02, 2022 |
|
ART Safety Considerations in Aging Patients With HIV
|
Nov 02, 2022 |
|
What Patients Want in HIV Treatment and Prevention: United States
|
Nov 01, 2022 |
|
Addressing Barriers to PrEP Uptake Among Black Cisgender Women
|
Oct 31, 2022 |
|
Addressing Barriers to PrEP Uptake Among Black MSM
|
Oct 27, 2022 |
|
London Perspective: Comorbidity and Adherence Considerations in Older Patients With HBV
|
Oct 27, 2022 |
|
Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance
|
Oct 20, 2022 |
|
Answering the Questions on Switching ART With Virologic Suppression
|
Oct 19, 2022 |
|
All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance
|
Oct 18, 2022 |
|
Meningococcal Disease: A Deadly, Unpredictable but Preventable Disease
|
Oct 12, 2022 |
|
Empowering Patients to “Age Healthy” With HIV
|
Oct 12, 2022 |
|
Managing Older Patients With Chronic HBV: A Global Perspective
|
Oct 10, 2022 |
|
Key HIV Studies Influencing My Practice Following AIDS 2022—Audio Redcap
|
Oct 04, 2022 |
|
Weight Gain and Cardiometabolic Toxicities in Patients With HIV
|
Oct 04, 2022 |
|
Switching ART in the Context of Pregnancy
|
Oct 03, 2022 |
|
My Lived Experience as a Woman Aging With HIV
|
Sep 29, 2022 |
|
Finding Our Voices: Older Women With HIV in Resource-Limited Settings
|
Sep 20, 2022 |
|
Long-Acting Cabotegravir for HIV Prevention
|
Sep 08, 2022 |
|
Piecing the Puzzle Together: Addressing Medical Challenges in Older PWH
|
Aug 25, 2022 |
|
Ending the HIV Epidemic: Reaching the Undiagnosed
|
Aug 24, 2022 |
|
Ending the HIV Epidemic: Care Pathways After HIV Testing
|
Aug 24, 2022 |
|
Ending the HIV Epidemic: Keys to Successful Treatment Initiation
|
Aug 24, 2022 |
|
Safety Considerations for HIV Treatments During Pregnancy
|
Aug 23, 2022 |
|
Linkage to Care for Patients With HDV
|
Aug 03, 2022 |
|
Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations
|
Aug 02, 2022 |
|
Switching to Long-Acting Cabotegravir Plus Rilpirivine for HIV Treatment: Assessing Candidacy and Patient Counseling
|
Jul 14, 2022 |
|
First Cohort With HIV: Paving the Path for the Future
|
Jul 06, 2022 |
|
Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap
|
Jul 06, 2022 |
|
Advancements in Viral Hepatitis From EASL 2022
|
Jul 05, 2022 |
|
Defining and Striving for HBV Cure: What’s in the Pipeline
|
Jun 30, 2022 |
|
My Perspective: Living With HIV Is Life Changing but Not Life Limiting
|
Jun 21, 2022 |
|
When Patients With Chronic HBV Infection Do Not Meet Indications for Immediate Treatment: The Critical Role of Ongoing Monitoring
|
May 26, 2022 |
|
Key Decisions in HIV Care: Postexposure Prophylaxis
|
May 26, 2022 |
|
Key Decisions in HIV Care: Treatment Considerations for Transgender PWH
|
May 25, 2022 |
|
Key Decisions in HIV Care: Choosing ART for Pediatric Patients
|
May 25, 2022 |
|
COVID-19: Outpatient Therapeutic Updates
|
May 24, 2022 |
|
RSV in Older Adults: Immunology and Vaccine Development
|
May 05, 2022 |
|
RSV in Older Adults: Epidemiology and Risk Factors
|
May 05, 2022 |
|
Adult HBV Vaccination: Current Vaccines and Vaccination Strategies
|
May 05, 2022 |
|
RSV in Older Adults: Identification and Impact
|
May 05, 2022 |
|
Adult HBV Vaccination: Identifying Individuals at Risk for Reduced Seroprotection
|
May 05, 2022 |
|
Adult HBV Vaccination: Overcoming Gaps to Lessen the Burden and Impact of HBV
|
May 05, 2022 |
|
Increasing Awareness of Hepatitis Delta
|
May 03, 2022 |
|
Why Everyone Should Be Screened for HCV and Treated If They Have It: Conversations Between Patient and Physician
|
May 03, 2022 |
|
Key Decisions in HIV Care: Considering Novel Therapies for HIV
|
May 02, 2022 |
|
A Model Intervention: Aiming for HCV Elimination in HIV-Positive MSM
|
Apr 27, 2022 |
|
COVID-19: Which Drug, When, and Why? Antiviral Agents
|
Apr 25, 2022 |
|
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
|
Apr 21, 2022 |
|
How Stigma and Socioeconomic Barriers Impede HCV Care: Conversations Between Patient and Physician
|
Apr 20, 2022 |
|
Long COVID
|
Apr 13, 2022 |
|
Importance of Screening for HCC in HBV: Patient and Physician Sharing Session #7
|
Apr 12, 2022 |
|
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
|
Apr 07, 2022 |
|
Key Decisions in HIV Care: Managing ART With Opportunistic Infections
|
Apr 05, 2022 |
|
Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1
|
Mar 30, 2022 |
|
The Ups and Downs of Living With HBV: Conversations Between Patient and Physician #4
|
Mar 25, 2022 |
|
Key Decisions in HIV Care: PrEP Considerations in Cisgender Men and Transgender Women
|
Mar 25, 2022 |
|
Key Decisions in HIV Care: PrEP Considerations in Cisgender Women
|
Mar 24, 2022 |
|
Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era
|
Mar 23, 2022 |
|
Key Decisions in HIV Care: Considerations for Long-Acting Injectable PrEP
|
Mar 21, 2022 |
|
Rational Use of New and Emerging Agents for Hepatitis Delta Virus
|
Mar 16, 2022 |
|
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
|
Mar 16, 2022 |
|
Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
|
Mar 15, 2022 |
|
HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy
|
Mar 15, 2022 |
|
Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap
|
Mar 14, 2022 |
|
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting
|
Mar 14, 2022 |
|
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP
|
Mar 14, 2022 |
|
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap
|
Mar 14, 2022 |
|
Monitoring and Treating Patients Coinfected With HBV and HDV
|
Mar 10, 2022 |
|
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3
|
Mar 07, 2022 |
|
Hepatitis Delta Treatment: Where We Are and Where We Are Headed
|
Mar 03, 2022 |
|
How Can We Destigmatize a Hepatitis B Diagnosis? Conversations Between Patient and Physician #2
|
Feb 24, 2022 |
|
Lessons From Lockdown: Caring for Patients With Hepatitis B Virus Infection in the COVID-19 Era—Audio Recap
|
Feb 24, 2022 |
|
COVID-19: Omicron Transmissibility, Severity, and Vaccine Effectiveness
|
Feb 22, 2022 |
|
Importance of Treatment for HBV: Patient and Physician Sharing Session #6
|
Feb 18, 2022 |
|
Key Decisions in HIV Care: Treating HIV/HCV Coinfection
|
Feb 16, 2022 |
|
My Management Strategies for NASH in Patients With HIV
|
Feb 15, 2022 |
|
Lessons From Lockdown: Hepatitis Delta Elimination Strategies in the COVID-19 Era
|
Feb 11, 2022 |
|
Key Decisions in HIV Care: Renal and Hepatic Considerations in Older PWH
|
Feb 10, 2022 |
|
Don’t Forget About the Liver! NASH in Patients with HIV: Answering the Questions Forum
|
Feb 09, 2022 |
|
NASH in PWH: Key Strategies for Screening and Identification
|
Feb 03, 2022 |
|
Key Decisions in HIV Care: Considering the Use of Proviral DNA Genotyping to Inform ART Choice
|
Feb 01, 2022 |
|
Tackling Racial Inequities in HIV Care Globally
|
Jan 26, 2022 |
|
Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance
|
Jan 25, 2022 |
|
Omicron Variant: Effects on Treatments for COVID-19
|
Jan 25, 2022 |
|
Tackling Racial Inequities in HIV Care in the United States
|
Jan 12, 2022 |
|
Key Decisions in HIV Care: ART Considerations With Coinfections
|
Jan 10, 2022 |
|
Key Decisions in HIV Care: Is There a Role for PIs in Current Practice?
|
Jan 06, 2022 |
|
COVID-19 Oral Antiviral Agents
|
Jan 06, 2022 |
|
Key Decisions in HIV Care: Is There a Role for NNRTIs in Current Practice?
|
Jan 06, 2022 |
|
Personal Perspectives on HIV PrEP Use: My Decision, My Experience
|
Jan 03, 2022 |
|
Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance
|
Dec 29, 2021 |
|
Individualized Choices in Antiretroviral Therapy: Present and Future
|
Dec 21, 2021 |
|
Key Decisions in HIV Care: Polypharmacy and Cardiovascular Risk Considerations in Older PWH
|
Dec 21, 2021 |
|
Universal Screening for Hepatitis Delta
|
Dec 20, 2021 |
|
Key Decisions in HIV Care: Assessing Candidacy for Long-Acting ART
|
Dec 16, 2021 |
|
Tackling Racial Inequalities in HBV Care Globally
|
Dec 15, 2021 |
|
Shingles in the COVID-19 Era: Increasing Shingles Vaccine Uptake—Audio Recap
|
Dec 14, 2021 |
|
COVID-19 Vaccination: Third Doses and Boosters
|
Dec 10, 2021 |
|
Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021
|
Dec 06, 2021 |
|
Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021
|
Dec 01, 2021 |
|
Key Studies Influencing My Practice Following EACS 2021—Audio Recap
|
Nov 30, 2021 |
|
Shingles in the COVID-19 Era: Vaccination for Prevention of Complications—Audio Recap
|
Nov 23, 2021 |
|
Key Decisions in HIV Care: Managing Suboptimal CD4+ Cell Count Increase Despite Suppressive ART
|
Nov 19, 2021 |
|
Tackling Racial Disparities in HCV Care: Global Edition
|
Nov 17, 2021 |
|
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
|
Nov 16, 2021 |
|
Shingles in the COVID-19 Era: Shingles Vaccination Guidelines—Audio Recap
|
Nov 11, 2021 |
|
Key Decisions in HIV Care: Switching to a 2-Drug Single-Tablet Regimen
|
Nov 10, 2021 |
|
Lessons From Lockdown: Perspectives on Hepatitis C Care in the US and Australia—Audio Recap
|
Nov 10, 2021 |
|
Should We Screen Patients With HIV for NAFLD/NASH?
|
Nov 10, 2021 |
|
Key Decisions in HIV Care: ART in Pregnancy
|
Nov 08, 2021 |
|
Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Audio Recap
|
Oct 29, 2021 |
|
Racial Disparities in COVID-19: Causes, Consequences, and Clinical Strategies—Audio Recap
|
Oct 29, 2021 |
|
The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP
|
Oct 21, 2021 |
|
A Long Journey to HCV Cure: Conversations Between Patient and Physician #1
|
Oct 19, 2021 |
|
New COVID-19 Data: A Case for Optimism?
|
Oct 14, 2021 |
|
Key Decisions in HIV Care: What to Do About Missed CAB + RPV LA Injections?
|
Oct 13, 2021 |
|
Key Decisions in HIV Care: Considerations for Maternal Weight Gain
|
Oct 12, 2021 |
|
Key HIV Studies Influencing My Practice Following IDWeek 2021 – Audio Recap
|
Oct 11, 2021 |
|
Audio Recap: Timely Treatment for COVID-19
|
Oct 11, 2021 |
|
Key Decisions in HIV Care: Rapid Initiation of ART
|
Sep 29, 2021 |
|
Key Decisions in HIV Care: Tenofovir Alafenamide in Pregnancy
|
Sep 29, 2021 |
|
Shingles in the COVID-19 Era: Risk Factors and Complications—Audio Recap
|
Sep 24, 2021 |
|
Key Decisions in HIV Care: Initiating Timely ART in a Newly Diagnosed Adolescent
|
Sep 23, 2021 |
|
Key Decisions in HIV Care: Considering Rapid ART in a Patient With Opioid Use Disorder
|
Sep 23, 2021 |
|
Emerging Long-Acting PrEP Options
|
Sep 16, 2021 |
|
Contemporary Management of HIV 2021: New Data From IAS 2021—Audio Recap, Part 2
|
Sep 14, 2021 |
|
The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19
|
Sep 14, 2021 |
|
Contemporary Management of HIV 2021: New Data From IAS 2021—Audio Recap, Part 1
|
Sep 08, 2021 |
|
Contemporary Management of HIV 2021: Heavily Treatment–Experienced Patients—Audio Recap, Part 3
|
Sep 07, 2021 |
|
Tackling Racial Disparities in HBV Care
|
Sep 03, 2021 |
|
Contemporary Management of HIV 2021: Heavily Treatment–Experienced Patients—Audio Recap Part 2
|
Sep 02, 2021 |
|
Contemporary Management of HIV 2021: Heavily Treatment–Experienced Patients—Audio Recap, Part 1
|
Sep 01, 2021 |
|
Key Decisions in HIV Care: Weight Gain in ART
|
Aug 30, 2021 |
|
Contemporary Management of HIV 2021: Emerging Paradigms in ART
|
Aug 25, 2021 |
|
Contemporary Management of HIV 2021: Modifying ART in Virologically Suppressed Patients
|
Aug 25, 2021 |
|
Conference Conversations: Pharmacist Perspectives From IAS 2021
|
Aug 23, 2021 |
|
Key Studies Influencing My Practice Following IAS 2021—Audio Recap
|
Aug 19, 2021 |
|
Optimizing Use of Oral HIV PrEP
|
Aug 12, 2021 |
|
The HBV Gray Zone: Patient and Physician Sharing Session #5
|
Jul 28, 2021 |
|
Hepatitis B Reactivation: Patient and Physician Sharing Session #4
|
Jul 26, 2021 |
|
Tackling Racial Disparities in HCV Care
|
Jul 22, 2021 |
|
Virtual EASL 2021: Rapid Audio Recap
|
Jul 19, 2021 |
|
An HIV Vaccine: An Unfulfilled Promise—Episode 4, Looking Toward a Fulfilled Promise
|
Jul 16, 2021 |
|
Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies
|
Jul 15, 2021 |
|
An HIV Vaccine: An Unfulfilled Promise—Episode 3, Increasing Global Advocacy and Funding
|
Jul 13, 2021 |
|
HIV-ASSIST: A Free, Online Tool for Individualized, Evidence-Based ART Selection—Audio Recap 2
|
Jul 08, 2021 |
|
Key Decisions in HIV Care: Initiating PrEP
|
Jul 07, 2021 |
|
Key Decisions in HIV Care: Switching to Long-Acting ART
|
Jul 07, 2021 |
|
Emerging Insights on Adverse Events During ART and Implications for Treatment
|
Jul 06, 2021 |
|
Contemporary Management of HIV 2021: Frontiers in HIV Prevention, Part 2—Audio Recap
|
Jun 30, 2021 |
|
An HIV Vaccine: An Unfulfilled Promise—Episode 2, Learning Through Failing
|
Jun 18, 2021 |
|
Contemporary Management of HIV 2021: First-line ART and Weight Gain—Audio Recap
|
Jun 15, 2021 |
|
Evolving Care of Heavily Treatment–Experienced Patients With HIV: Answering the Questions
|
Jun 15, 2021 |
|
Optimizing Switch Strategies for Patients With Viral Suppression
|
Jun 10, 2021 |
|
Contemporary Management of HIV 2021: Frontiers in HIV Prevention—Audio Recap
|
Jun 02, 2021 |
|
An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer
|
May 20, 2021 |
|
Contemporary Management of HIV 2021: New Data from CROI 2021—Audio Recap
|
May 18, 2021 |
|
HIV-ASSIST: A Free, Online Tool for Individualized, Evidence-Based ART Selection—Audio Recap
|
May 18, 2021 |
|
To Treat or Not to Treat: Patient and Physician Sharing Session #3
|
May 11, 2021 |
|
Contemporary Management of HIV 2021: Initiating First-line ART—Audio Recap
|
May 07, 2021 |
|
Managing HIV in Aging Patients: Answering the Questions, Part 4
|
May 03, 2021 |
|
Cases and Controversies in HIV: ART Simplification
|
Apr 27, 2021 |
|
Cases and Controversies in HIV: ART and Pregnancy
|
Apr 26, 2021 |
|
Cases and Controversies in HIV: ARV-Associated Weight Gain
|
Apr 23, 2021 |
|
Stigma as a Barrier to HBV Care: Patient and Physician Sharing Session #2
|
Apr 12, 2021 |
|
Starting HBV Treatment in Pregnancy: Patient and Physician Sharing Session #1
|
Mar 26, 2021 |
|
Virtual CROI 2021 – Rapid Recap
|
Mar 18, 2021 |
|
COVID-19: Answering the Questions, Part 17
|
Mar 09, 2021 |
|
4th HIV Research for Prevention Conference (HIVR4P // Virtual)—Rapid Recap
|
Feb 18, 2021 |
|
The IAS COVID-19 Conference: Prevention – Rapid Recap
|
Feb 18, 2021 |
|
COVID-19: Answering the Questions, Part 16
|
Feb 12, 2021 |
|
Managing HIV in Aging Patients: Answering the Questions, Part 3
|
Feb 10, 2021 |
|
COVID-19: Answering the Questions, Part 15
|
Jan 25, 2021 |
|
COVID-19: Answering the Questions, Part 14
|
Dec 31, 2020 |
|
Contemporary Management of HIV: Evolving Issues in First-line Combination Therapy
|
Dec 29, 2020 |
|
Ending the HIV Epidemic: Strategies for Preventing New Infections
|
Dec 24, 2020 |
|
Contemporary Management of HIV: Heavily Treatment–Experienced Patients
|
Dec 18, 2020 |
|
Ending the HIV Epidemic: Strategies for Achieving Rapid and Durable Virologic Suppression
|
Dec 08, 2020 |
|
COVID-19: Answering the Questions, Part 13
|
Dec 08, 2020 |
|
Viral Hepatitis Data From AASLD 2020 – Rapid Recap
|
Nov 25, 2020 |
|
What’s New in HIV Treatment Safety and Tolerability: Data From 2020 Conferences
|
Nov 23, 2020 |
|
Managing HIV in Aging Patients: Answering the Questions, Part 2
|
Nov 19, 2020 |
|
Contemporary Management of HIV: ART Strategies for Complex HIV Cases
|
Nov 17, 2020 |
|
COVID-19: Answering the Questions, Part 12
|
Nov 09, 2020 |
|
Ending the HIV Epidemic: Strategies for Earlier Diagnosis, Linkage to Care, and Outbreak Response
|
Nov 04, 2020 |
|
COVID-19 Data From IDWeek 2020 – Rapid Recap
|
Oct 30, 2020 |
|
COVID-19: Answering the Questions, Part 11
|
Oct 29, 2020 |
|
HIV Glasgow 2020 Virtual – Rapid Recap
|
Oct 22, 2020 |
|
COVID-19: Answering the Questions, Part 10
|
Oct 16, 2020 |
|
Virtual ECCVID 2020 Conference – Rapid Recap
|
Oct 16, 2020 |
|
COVID-19: Answering the Questions, Part 9
|
Oct 09, 2020 |
|
COVID-19: Answering the Questions, Part 8
|
Oct 06, 2020 |
|
Contemporary Management of HIV: Selecting Among Current ART Regimens for Initial ART
|
Oct 02, 2020 |
|
COVID-19: Answering the Questions, Part 7
|
Sep 25, 2020 |
|
COVID-19: Answering the Questions, Part 6
|
Sep 23, 2020 |
|
Managing HIV in Aging Patients: Answering the Questions, Part 1
|
Sep 17, 2020 |
|
EASL 2020 Virtual Conference: Rapid Audio Recap
|
Sep 14, 2020 |
|
COVID-19: Answering the Questions, Part 5
|
Sep 02, 2020 |
|
Virtual COVID-19 2020 Conference: Rapid Audio Recap
|
Aug 19, 2020 |
|
AIDS 2020: Virtual – Rapid Audio Recap
|
Aug 14, 2020 |
|
COVID-19: Answering the Questions, Part 4
|
Jul 23, 2020 |
|
Benefits of and Need for Integrated Addiction and Infectious Disease Care
|
Jul 09, 2020 |
|
COVID-19: Answering the Questions, Part 3
|
Jun 29, 2020 |
|
COVID-19: Answering the Questions, Part 2
|
Jun 12, 2020 |
|
Addressing Age-Related Comorbidities Among People With HIV
|
Jun 05, 2020 |
|
COVID-19: Answering the Questions, Part 1
|
Jun 05, 2020 |
|
Weight Gain During HIV Treatment and the Latest in HIV Prevention
|
Jun 05, 2020 |